⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002111400

Furuta Milano

Reports to the SEC for 1 company · TOKYO

Transactions

7

Companies

1

Filings

2

CIK

0002111400

Forms 4 and 5

Insider transactions

7 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-10	TAKTAKEDA PHARMACEUTICAL CO LTD · Tax Obligation AwardD Disposition to Issuer	Director, Chief Financial Officer	DDisposition to Issuer	−16.6K sh	$4931.50	−$82M	0
2026-07-01	TAKTAKEDA PHARMACEUTICAL CO LTDA Award	Director, Chief Financial Officer	AAward	+12.3K sh	—	—	70,200
2026-07-01	TAKTAKEDA PHARMACEUTICAL CO LTD · Tax Obligation AwardA Award	Director, Chief Financial Officer	AAward	+4,288 sh	—	—	11,741
2026-07-01	TAKTAKEDA PHARMACEUTICAL CO LTD · Tax Obligation AwardA Award	Director, Chief Financial Officer	AAward	+4,288 sh	—	—	8,482
2026-07-01	TAKTAKEDA PHARMACEUTICAL CO LTD · Tax Obligation AwardA Award	Director, Chief Financial Officer	AAward	+4,288 sh	—	—	4,288
2026-04-27	TAKTAKEDA PHARMACEUTICAL CO LTD · Tax Obligation AwardA Award	Director, Chief Financial Officer	AAward	+7,814 sh	—	—	16,619
2026-04-27	TAKTAKEDA PHARMACEUTICAL CO LTDA Award	Director, Chief Financial Officer	AAward	+7,800 sh	—	—	57,900

Recent filings

2

Accepted (ET)
Jul 64
Furuta Milano0001395064-26-000260
SEC(opens sec.gov)
Apr 284
Furuta Milano0001395064-26-000138
SEC(opens sec.gov)

Companies

1

TAKEDA PHARMACEUTICAL CO LTDDirector, Chief Financial OfficerTAK

Address

1-1, NIHONBASHI-HONCHO 2-CHOME CHUO-KU

TOKYO, 103-8668